Celtek Peptides vs Prime Peptides for Research-Lab Procurement
Celtek Peptides leads Prime Peptides in the supplied procurement scorecard, with stronger scores across testing, catalog, website, service, and stability criteria.
Yao Lin
From Patent Sequence to Peer-Reviewed Study: Tracing CB5005 Across the Research Record
A chronological examination of the CB5005 record, from its patent sequence and early cell experiments to later peer-reviewed studies in cells, spheroids, and mice.
Pharmacokinetics vs Biodistribution in Peptide Delivery Studies
Pharmacokinetics describes how measured peptide concentration changes over time, while biodistribution adds tissue location. Learn what each study can establish, where common assays fall short, and when both are needed.
Nuclear vs Cytoplasmic Western Blots for NF-kB Translocation
A practical guide to fractionating cells, validating nuclear and cytoplasmic purity, normalizing p65 signals, troubleshooting contamination, and limiting conclusions to what an NF-κB translocation assay can establish.
Direct Translocation vs Endocytosis: Two Routes Proposed for Cell-Penetrating Peptides
Cell-penetrating peptides may cross the plasma membrane directly, enter through endocytosis, or use both routes. The apparent mechanism depends on the peptide, cargo, concentration, cell system, and assay.
From Cell Culture to Animal Models to Human Trials: How Biotechnology Evidence Changes at Each Step
A mechanism-first guide to the biotechnology evidence ladder, from biochemical assays and cultured cells to nonclinical models, human trials, regulatory review, and post-market monitoring.
Constitutive NF-κB Activation in Cancer Models
Constitutive NF-κB activation is an experimental conclusion, not a synonym for one positive assay. This guide explains the evidence needed to demonstrate persistent baseline signaling and pathway dependence in cancer models.
Cell-Penetrating Peptide–Protein Conjugates: Linkers, Cargo Size, and Functional Readouts
A practical guide to CPP–protein architectures, linker selection, cargo-dependent behavior, and the evidence needed to demonstrate functional intracellular delivery.
How Cargo Size Changes Cell-Penetrating Peptide Delivery
Cell-penetrating peptides do not have one universal cargo-size limit. Productive delivery depends on the complete construct, its uptake route, intracellular release, localization, and retained activity.
Tissue Selectivity vs Cell Penetration: Why They Are Different Problems
A cell-penetrating peptide may enter cultured cells efficiently yet fail to deliver its cargo selectively to a target tissue in vivo. This guide explains the biological distinction and the evidence needed to evaluate selectivity.